Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2009 2
2010 3
2011 2
2013 1
2014 2
2015 2
2016 1
2020 1
2021 3
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).
Khaleva E, Rattu A, Brightling C, Bush A, Bossios A, Bourdin A, Chung KF, Chaudhuri R, Coleman C, Dahlén SE, Djukanovic R, Deschildre A, Fleming L, Fowler SJ, Gupta A, Hamelmann E, Hashimoto S, Hedlin G, Koppelman GH, Melén E, Murray CS, Pilette C, Porsbjerg C, Pike KC, Rusconi F, Williams C, Ahrens B, Alter P, Anckers F, van den Berge M, Blumchen K, Brusselle G, Clarke GW, Cunoosamy D, Dahlén B, Dixey P, Exley A, Frey U, Gaillard EA, Giovannini-Chami L, Grigg J, Hartenstein D, Heaney LG, Karadag B, Kaul S, Kull I, Licari A, Maitland-van der Zee AH, Mahler V, Schoos AM, Nagakumar P, Negus J, Nielsen H, Paton J, Pijnenburg M, Ramiconi V, Romagosa Vilarnau S, Principe S, Rutjes N, Saglani S, Seddon P, Singer F, Staudinger H, Turner S, Vijverberg S, Winders T, Yasinska V, Roberts G; COMSA Working Group in the 3TR Consortium. Khaleva E, et al. Among authors: kaul s. Eur Respir J. 2023 Apr 3;61(4):2200606. doi: 10.1183/13993003.00606-2022. Print 2023 Apr. Eur Respir J. 2023. PMID: 36229046 Free PMC article. Review.
[Recombinant allergens, peptides, and virus-like particles for allergy immunotherapy].
Holzhauser T, Schuler F, Dudek S, Kaul S, Vieths S, Mahler V. Holzhauser T, et al. Among authors: kaul s. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Nov;63(11):1412-1423. doi: 10.1007/s00103-020-03231-7. Epub 2020 Oct 23. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 33095280 Free PMC article. Review. German.
DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy.
Pfaar O, Hamelmann E, Taube C, Wagenmann M, Wedi B, Werfel T, Bartel D, Bonertz A, Hartenstein D, Kaul S, Mahler V, Worm M. Pfaar O, et al. Among authors: kaul s. Allergol Select. 2023 Dec 12;7:229-235. doi: 10.5414/ALX02450E. eCollection 2023. Allergol Select. 2023. PMID: 38143938 Free PMC article.
Placebo effects in allergen immunotherapy-An EAACI Task Force Position Paper.
Pfaar O, Agache I, Bergmann KC, Bindslev-Jensen C, Bousquet J, Creticos PS, Devillier P, Durham SR, Hellings P, Kaul S, Kleine-Tebbe J, Klimek L, Jacobsen L, Jutel M, Muraro A, Papadopoulos NG, Rief W, Scadding GK, Schedlowski M, Shamji MH, Sturm G, van Ree R, Vidal C, Vieths S, Wedi B, Gerth van Wijk R, Frew AJ. Pfaar O, et al. Among authors: kaul s. Allergy. 2021 Mar;76(3):629-647. doi: 10.1111/all.14331. Allergy. 2021. PMID: 32324902
Regulatory aspects of specific immunotherapy in Europe.
Kaul S, Englert L, May S, Vieths S. Kaul S, et al. Curr Opin Allergy Clin Immunol. 2010 Dec;10(6):594-602. doi: 10.1097/ACI.0b013e32833fd5d2. Curr Opin Allergy Clin Immunol. 2010. PMID: 20864886 Review.
22 results